Skip to main content
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
23.43
+1.32 (5.97%)
Mar 9, 2026, 3:38 PM EDT - Market open

Arcus Biosciences Revenue

In the year 2025, Arcus Biosciences had annual revenue of $247.00M, down -4.26%. Arcus Biosciences had revenue of $33.00M in the quarter ending December 31, 2025, with 26.92% growth.

Revenue (ttm)
$247.00M
Revenue Growth
-4.26%
P/S Ratio
11.42
Revenue / Employee
$410,982
Employees
601
Market Cap
2.94B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025247.00M-11.00M-4.26%
Dec 31, 2024258.00M141.00M120.51%
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Apellis Pharmaceuticals 1.00B
Telix Pharmaceuticals 803.79M
Catalyst Pharmaceuticals 588.99M
Travere Therapeutics 490.73M
Arcutis Biotherapeutics 376.07M
IDEAYA Biosciences 218.71M
Beam Therapeutics 139.74M
Viridian Therapeutics 70.85M
Revenue Rankings

RCUS News

More News